Mural Oncology Stock (NASDAQ: MURA) stock price, news, charts, stock research, profile.
Open | $3.17 |
Close | $3.14 |
Volume / Avg. | 2.45M / 171.57K |
Day Range | 3.03 - 3.21 |
52 Wk Range | 3.05 - 17.00 |
Market Cap | $53.14M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 8.02% |
Days to Cover | 8.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mural Oncology (NASDAQ:MURA) through any online brokerage.
Other companies in Mural Oncology’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS), CollPlant Biotechnologies (NASDAQ:CLGN) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for Mural Oncology.
Mural Oncology has a consensus price target of $14.00.
The stock price for Mural Oncology (NASDAQ: MURA) is $3.14 last updated June 28, 2024 at 4:19 PM EDT.
There are no upcoming dividends for Mural Oncology.
Mural Oncology’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Mural Oncology.
Mural Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.